Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ORIFARM GENERICS A/S
A/S
Active
Reklamebeskyttelse
CVR 25674030
Energivej 15, 5260
Odense S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2000 · 25 years old
281 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ORIFARM GENERICS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
708M
1B
2B
3B
1.8B
2021
2.1B
2022
2.1B
2023
2.3B
2024
2.5B
2025
EBITDA
DKK millions
238M
178M
119M
59M
0M
190M
2021
80M
-58%
2022
109M
+36%
2023
109M
0%
2024
119M
+9%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.757.348
2.074.832
2.137.930
2.343.003
2.463.585
Staff expenses
-138.954
-181.415
-229.007
-242.890
-280.151
EBITDA
190.375
80.073
108.671
109.414
119.059
Depreciation & amort.
-9.727
-10.520
-13.041
-10.358
-10.898
EBIT
180.648
69.553
95.630
99.056
108.161
Net financials
10.101
-19
-15.369
-22.014
-9.304
Profit before tax
190.749
69.534
80.261
77.042
98.857
Tax
40.609
15.072
17.333
17.182
21.680
Net profit
150.140
54.462
62.928
59.860
77.177
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.172.126
1.345.179
1.382.406
1.040.284
1.258.605
Equity
527.257
431.719
494.647
554.507
496.304
Long-term debt
0
0
0
0
0
Short-term debt
634.665
903.030
876.907
473.102
751.382
Total debt
634.665
903.030
876.907
473.102
751.382
Financial ratios
5-year trend
EBITDA-margin
4.8%
This company
15.8%
Market median
-70% vs market
2021
2025
Soliditetsgrad
39.4%
This company
38.2%
Market median
+3% vs market
2021
2025
Egenkapitalforrentning
15.6%
This company
18.4%
Market median
+15% vs market
2021
2025
Nettoresultatgrad
3.1%
This company
8.1%
Market median
-62% vs market
2021
2025
Aktivomsætning
1.96×
This company
1.12×
Market median
+75% vs market
2021
2025
Gæld/egenkapital
1.54×
This company
0.62×
Market median
-148% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ORIFARM GENERICS A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
